Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer’s therapies, criteria for selecting neurology residents

Neurology Today in 5

English - December 01, 2022 05:00 - 5 minutes - 7.27 MB - ★★★★★ - 14 ratings
Science Health & Fitness Medicine neurology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children.

Next Episode: Rituximab for MS, food security and cognition, in utero treatment for Pompe disease

In this week’s podcast, Neurology Today’s editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer’s therapies, and criteria program directors apply in selecting neurology residents.